- Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?2014 | Faculty of Medicine in Pilsen
- Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study2016 | Faculty of Medicine in Pilsen
- Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 20132016 | Faculty of Medicine in Pilsen
- Factors effecting efficacy in anti-TNF therapy in clinical practice: Experiences from national registry ATTRA2014 | First Faculty of Medicine
- AURIEL-PsO: a randomized, double-blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate-to-severe chronic plaque-type psoriasis2020 | Second Faculty of Medicine